Status:
WITHDRAWN
HCV Post-Exposure Prophylaxis for Health Care Workers
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Gilead Sciences
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore needles.
Detailed Description
The goal of this study is to assess the safety and tolerability of the use of sofosbuvir-velpatasvir in the setting of post-exposure prophylaxis among Health Care Workers exposed to HCV from needlesti...
Eligibility Criteria
Inclusion
- Healthcare worker with exposure through needlestick injury with hollow-bore needles to source patients who are HCV positive
- Healthcare worker must be HCV Ab-
Exclusion
- HCV Ab positive
- HCV Ab negative and HCV RNA greater than 1000 IU/ml
- Active malignancy
- Positive urine pregnancy test
Key Trial Info
Start Date :
August 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03313414
Start Date
August 13 2019
End Date
January 16 2020
Last Update
January 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114